Second Affiliated Hospital Of Xi'an Jiaotong University

This study is testing a new combination treatment to prevent liver cancer from returning after surgery. It is for patients whose cancer has a specific high-risk feature called 'tumor budding.' Researchers will give patients two drugs: one to break down tissue barriers around the …